- Home
- MAIA vs ETON Comparison
MAIA vs ETON Comparison
Compare MAIA & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAIA
- ETON
- Stock Information
- Founded
- MAIA 2018
- ETON 2017
- Country
- MAIA United States
- ETON United States
- Employees
- MAIA N/A
- ETON N/A
- Industry
- MAIA Biotechnology: Pharmaceutical Preparations
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- MAIA Health Care
- ETON Health Care
- Exchange
- MAIA Nasdaq
- ETON Nasdaq
- Market Cap
- MAIA 62.4M
- ETON 199.5M
- IPO Year
- MAIA 2022
- ETON 2018
- Fundamental
- Price
- MAIA $2.82
- ETON $8.77
- Analyst Decision
- MAIA
- ETON Strong Buy
- Analyst Count
- MAIA 0
- ETON 3
- Target Price
- MAIA N/A
- ETON $12.00
- AVG Volume (30 Days)
- MAIA 60.0K
- ETON 214.1K
- Earning Date
- MAIA 11-05-2024
- ETON 11-11-2024
- Dividend Yield
- MAIA N/A
- ETON N/A
- EPS Growth
- MAIA N/A
- ETON N/A
- EPS
- MAIA N/A
- ETON N/A
- Revenue
- MAIA N/A
- ETON $31,381,000.00
- Revenue This Year
- MAIA N/A
- ETON $19.61
- Revenue Next Year
- MAIA N/A
- ETON $35.39
- P/E Ratio
- MAIA N/A
- ETON N/A
- Revenue Growth
- MAIA N/A
- ETON 8.14
- 52 Week Low
- MAIA $0.82
- ETON $3.03
- 52 Week High
- MAIA $5.99
- ETON $8.66
- Technical
- Relative Strength Index (RSI)
- MAIA 50.98
- ETON 76.07
- Support Level
- MAIA $2.36
- ETON $7.58
- Resistance Level
- MAIA $2.72
- ETON $8.66
- Average True Range (ATR)
- MAIA 0.22
- ETON 0.42
- MACD
- MAIA 0.02
- ETON -0.07
- Stochastic Oscillator
- MAIA 72.28
- ETON 91.49
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.